DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Scott Weiner will be moderating a panel, The Partnering Conundrum: To Partner or Not to Partner, That is the Question..., at the Bio 2011 conference in Washington, D.C.
News | 06. 28. 2011
